Owlet Launches Owlet360™ in the UK and Ireland, Bringing Data-Driven Reassurance to More Families
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Key Terms
subscription servicefinancial
A subscription service is a business model where customers pay recurring fees to access a product or service on an ongoing basis, like a magazine subscription or a streaming app. For investors it matters because those steady payments create more predictable revenue and cash flow; the number of subscribers, how fast it grows, and how long customers keep paying show a company’s financial health and potential value, similar to owning a rental that stays consistently occupied.
pulse ratemedical
Pulse rate is the number of times the heart beats per minute, typically measured at the wrist or neck, and reflects how hard the body is working to circulate blood. Investors watch pulse rate because sustained increases or decreases can signal patient responses or side effects in clinical trials, influence regulatory assessments, and affect demand for treatments and health devices. Think of it like an engine’s RPMs: changes can indicate normal activity or a potential problem that matters to outcomes and forecasts.
oxygen levelmedical
The oxygen level is the amount of oxygen carried in a person’s blood, usually expressed as a percentage showing how fully the blood’s oxygen-carrying capacity is being used. It matters to investors because changes in oxygen levels are a key measure of patient health and treatment effectiveness, so they can affect clinical trial outcomes, safety signals, regulatory decisions and demand for medical devices or therapies—think of it as a fuel gauge for the body.
recurring-revenue modelfinancial
A recurring-revenue model is a business setup where customers pay regularly—monthly, annually, or per usage—for ongoing access to a product or service, like a subscription or utility bill. For investors it matters because predictable, repeat income makes future cash flows easier to forecast, values the company higher when customer retention is strong, and highlights risks such as churn or rising acquisition costs that can erode long-term profitability.
A new subscription service for Owlet users turns baby health and sleep trends into clear, personalized guidance, while core health tracking and notification features remain free.
LONDON--(BUSINESS WIRE)--
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the UK and Ireland launch of Owlet360™, a new subscription service designed to give parents a deeper, personalized understanding of their baby’s sleep and daily trends.
Owlet announces the UK and Ireland launch of Owlet360™, a new subscription service designed to give parents a deeper, personalized understanding of their baby’s sleep and daily trends.
Built for families using medically-certified Dream Sock® and Dream Sight™ or Owlet Cam® 2, Owlet360 leverages Owlet’s unique infant dataset to deliver actionable insights and context, helping parents feel more confident in everyday decisions. The Company emphasizes that live vital monitoring of pulse rate and oxygen level, and real-time notifications through the Owlet Dream App, remain free of charge, consistent with its mission to improve access to at-home infant care.
New parenthood is joyful – and relentlessly demanding. In the UK, sleep deprivation is a near-universal early-parent experience, with surveys showing around 59% of parents of babies under one reporting their baby sleeps less than four hours at a stretch, and many worrying their baby “should” be sleeping longer. Owlet360 aims to be a supportive companion, helping parents see how their baby’s sleep and daily patterns evolve over time and how those trends compare across Owlet’s broad population of babies.
“Owlet’s insights platform is grounded in one of the world’s largest real-world infant datasets from more than 2.5 million babies monitored,” said Jonathan Harris, Owlet’s President and CEO. “Globally, Owlet has tracked trillions of heartbeats, and these learnings now power personalized interpretations for our UK and Irish customer base. Owlet360 is the next step in our pediatric care ecosystem, turning trusted vitals and sleep data into personalized insights that help families feel supported day to day.”
Owlet360 extends the experience parents already know in the Owlet Dream App, providing:
Deeper daily summaries and weekly trend views for sleep, pulse rate, oxygen, movement, and comfort temperature.
Comparisons to Owlet’s vast infant dataset, helping parents understand what’s typical for their baby’s age.
Sleep insights with weekly trend tracking and practical guidance as your baby’s patterns evolve or they go through key milestones.
Room environment trends, including temperature and humidity over time.
More video moments and notifications, letting families save and share clips when Baby is moving or crying is detected (for compatible Dream Sight users).
Owlet360 is already demonstrating meaningful adoption and value for families. Following the U.S. launch earlier this year, the service has grown rapidly to more than 90,000 subscribers, highlighting both its relevance in the parenting journey and the durability of Owlet’s recurring-revenue model.
Owlet360 is available now to Owlet Dream App users across the UK and Ireland, with a seven-day free trial for eligible new and existing customers. The service is currently offered via a monthly or yearly subscription, with additional platform expansions planned in the future. To learn more about Owlet and its product offerings, visit owletbabycare.co.uk.
About Owlet, Inc.
Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child’s well-being, support restful sleep, and provide peace of mind anywhere. Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children's well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Our mission is simple yet ambitious: to give every baby and every family the best possible start in life. Learn more at www.owletcare.com and follow us on LinkedIn and Instagram for company news and updates.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company’s launch of Owlet360 in the U.K. and Ireland and the anticipated impacts thereof; the Company’s expectations regarding product adoption, subscriber engagement, and growth trends relating to Owlet360 and its broader platform; the Company’s ability to expand availability of its products and services in additional markets; and the Company’s ability to enhance its technology, product ecosystem, and service offerings over time. In some cases, you can identify forward-looking statements by terms such as “estimate,” “may,” “believes,” “plans,” “expects,” “anticipates,” “intends,” “goal,” “potential,” “continues,” the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company’s expectations at the time such statements are made, speak only as of the dates they are made, and are susceptible to a number of risks, uncertainties, and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company’s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements. Many important factors could affect the Company’s future results and cause those results to differ materially from those expressed in or implied by the Company’s forward-looking statements. Such factors include, but are not limited to: (i) the commercial success of Owlet’s products, including Owlet360, and the Company’s ability to support, scale and maintain its subscription services; (ii) the regulatory pathway for Owlet’s products, including submissions to, actions taken by and decisions and responses from regulators, such as the FDA and similar regulators outside of the United States, as well as Owlet’s ability to obtain and maintain regulatory approval or certification for its products and comply with ongoing regulatory requirements; (iii) the Company’s and its partners’ obligations relating to data privacy, security and the exchange and use of health information, and risks of cybersecurity incidents or changes in applicable standards or interpretations; (iv) the performance of, and Owlet’s ability to maintain and expand, its relationship with third-party technology, cloud, manufacturing and distribution partners; (v) Owlet’s competition and the Company’s ability to profitably grow and manage growth; (vi) the ability of Owlet to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (vii) Owlet’s ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements concerning privacy and data protection; (viii) Owlet’s ability to maintain relationships with channel partners, customers, manufacturers and suppliers; (ix) impacts from compliance with applicable laws or regulations; (x) the impact of and disruption to Owlet’s business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company’s control; (xi) adverse impacts from other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; and (xii) other risks and uncertainties set forth in the Company’s other releases, public statements and filings with the U.S. Securities and Exchange Commission (“SEC”), including those identified in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and as any such factors may be updated from time to time in the Company’s other filings with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and it is impossible for the Company to predict such events or how they may affect Owlet. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events or otherwise, although Owlet may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.
